Independent Director · KalVista Pharmaceuticals, Inc. (KALV)

Nancy Stuart director compensation at KalVista (FY2024): $146K

Fiscal year 2024 director compensation for Nancy Stuart at KalVista Pharmaceuticals, Inc.. Every figure below is printed as the company filed it and cited to the filing it came from.

Director compensation as of the proxy filed August 21, 2025 (DEF 14A). Open the filing on EDGAR.

Free

Get Nancy Stuart’s full pay file as a PDF — free

More than this page: up to 10 years of Nancy’s pay history, a side-by-side peer comparison, and a one-page board summary — the whole file, yours now and by email.

Also free: The Pay Desk, the weekly executive pay briefing.

Or track Nancy Stuart and every company like it: Velarion Intel, free for 3 days, no card →

What they were paid

KalVista Pharmaceuticals Director Compensation Table · all 3 fiscal years held
In US dollars, as KalVista Pharmaceuticals reports it. Most recent year first. Totals are the company’s disclosed totals.
Fiscal yearCash feesStock awardsOption awardsOtherTotal
FY2025$41,666—$256,626—$298,293
FY2024$62,500$0$83,206$0$145,706
FY2023$62,500—$74,099$0$136,599

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: KalVista Pharmaceuticals, Inc. DEF 14A filed August 21, 2025, accession 0001193125-25-185353, and prior-year filings. Open the filing on EDGAR.

How this page was built: the KalVista Pharmaceuticals, Inc. filed document, accession 0001193125-25-185353. Every figure is read from that document and cited to the page and table it appears in. Filed August 21, 2025.

Get the KalVista Pharmaceuticals Board Governance Report

$145,706 Nancy Stuart, FY2024 total director compensation

$500

The free page is the headline figures. The board report is director pay, board composition and committee fees combined into the same kind of document.

Data as of August 21, 2025 · Source: Velarion Executive Compensation Database, deposited on Zenodo (doi:10.5281/zenodo.22283855).

How this board is paid

company policy · FY2024

KalVista Pharmaceuticals pays directors a $42,500 cash retainer and $83,206 in Options.

Committees

FY2024 · as the proxy prints them

Audit · Nominating/Governance

The rest of the KalVista Pharmaceuticals board

FY2024 · as the company reported each
DirectorRoleFY2024 total
Benjamin L. PalleikoDirector—
Brian J. G. PereiraIndependent Director$170,706
Edward W. UnkartIndependent Director$145,706
Laurence ReidIndependent Director$142,500
Patrick TreanorIndependent Director$137,547
William FaireyIndependent Director$133,206

The full KalVista Pharmaceuticals compensation record

free company brief

This page is one director within KalVista Pharmaceuticals's record. The company brief lists every named executive and director, each linking to their own page.

Order KALV

Add the email the receipt and the PDF go to, then press the report you want. Each button opens its own card payment on Stripe.

Receipt, invoice, and report delivery. Guest checkout, no account required, secure payment by Stripe.

Board Governance Report